Explore the epigenetic mechanisms underlying non-small cell lung cancer metastasis to the brain in this 15-minute conference talk from the 2022 Cancer Genomics Consortium Annual Meeting. Delve into Jennifer Karlow's CGC Trainee Award-winning research on the reprogramming of brain development pathways during the metastatic process. Gain insights into the latest findings in cancer genomics and their potential implications for accurate diagnosis and targeted therapies for lung cancer patients with brain metastases.
Epigenetic Reprogramming of Brain Development Pathways During Non-Small Cell Lung Cancer Metastasis
Cancer Genomics Consortium via YouTube
Overview
Syllabus
Epigenetic Reprogramming of Brain Development Pathways During Non-Small Cell Lung Cancer Metastasis
Taught by
Cancer Genomics Consortium
Related Courses
-
Two Co-occurring Driver Mutations in Primary Lung Adenocarcinoma - Who's Driving Treatment?
-
Whole Exome Sequencing Reveals Timing and Origins of Metastasis in Lung Cancer
-
Development of a Novel Targeted NGS Panel for Analysis of DNA Methylation Biomarkers in Lung Cancer
-
Prognostic Significance of MYC Copy Number Gain in Large B-Cell Lymphoma - FISH Analysis
-
Clinical, Cytogenetic and Genomic Profiling of B-Other Acute Lymphoblastic Leukemia - An Indian Cohort Study
-
Long Molecule Footprints of Complex Cancer Genome Structure - Invited Presentation
